Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2018.10.065
Abstract: There is a growing interest in developing inhibitors of the neonatal Fc-receptor, FcRn, for use in the treatment for humoral autoimmune conditions. We have developed a new physiologically based pharmacokinetic model that is capable of…
read more here.
Keywords:
based pharmacokinetic;
mice rats;
anti fcrn;
physiologically based ... See more keywords